CMPS: Compass Pathways Plc
About
Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
Current Value
$4.771 Year Return
Current Value
$4.771 Year Return
Key Details
Market Cap
$325.68M
P/E Ratio
-2.16
1Y Stock Return
-18.35%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
1.7
Strategies that include CMPS
Stock's related to CMPS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NVRI | 40.40% | $552.13M | +20.03% | 0.00% |
| ALEC | 40.22% | $377.04M | -19.46% | 0.00% |
| PLRX | 39.57% | $778.32M | -9.55% | 0.00% |
| CLDT | 38.13% | $425.53M | -12.03% | 3.24% |
| RCKY | 37.74% | $155.86M | -17.74% | 2.95% |
| ANIK | 37.66% | $249.56M | -17.52% | 0.00% |
| XMTR | 37.27% | $1.48B | +50.13% | 0.00% |
| MARA | 36.60% | $6.39B | +92.63% | 0.00% |
| LOVE | 35.97% | $513.90M | +78.25% | 0.00% |
| ALLO | 35.61% | $444.50M | -24.82% | 0.00% |
| BOC | 35.58% | $456.18M | -1.56% | 0.00% |
| VYGR | 35.58% | $287.88M | -21.46% | 0.00% |
| HII | 35.16% | $7.50B | -19.92% | 2.70% |
| EDIT | 35.04% | $204.72M | -75.49% | 0.00% |
| CRNX | 34.77% | $5.12B | +84.27% | 0.00% |
| CC | 34.76% | $2.82B | -27.44% | 5.31% |
| MG | 34.41% | $282.81M | +42.06% | 0.00% |
| SRI | 33.78% | $166.13M | -63.46% | 0.00% |
| CSTL | 33.73% | $808.57M | +48.97% | 0.00% |
| RGNX | 33.14% | $473.65M | -51.96% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NYT | -0.03% | $8.54B | +15.47% | 0.96% |
| ACGL | 0.07% | $36.00B | +16.84% | 0.00% |
| VZIO | 0.08% | $2.29B | +67.76% | 0.00% |
| CME | 0.11% | $82.76B | +9.21% | 1.98% |
| NERV | 0.14% | $14.69M | -58.00% | 0.00% |
| ASAI | 0.17% | $1.65B | -53.36% | 0.00% |
| STG | -0.19% | $35.67M | +7.92% | 0.00% |
| NG | -0.20% | $1.22B | -5.91% | 0.00% |
| ASPS | -0.21% | $22.36M | -80.26% | 0.00% |
| KNOP | 0.21% | $210.40M | +11.75% | 1.68% |
| GIS | -0.22% | $34.85B | -2.91% | 3.78% |
| HQY | -0.27% | $8.97B | +52.15% | 0.00% |
| SO | -0.28% | $96.74B | +26.76% | 3.24% |
| NNVC | 0.30% | $19.66M | +25.69% | 0.00% |
| AIFU | -0.30% | $67.49M | -83.02% | 0.00% |
| PLMR | 0.32% | $2.84B | +79.77% | 0.00% |
| NLOP | -0.33% | $458.04M | +94.60% | 0.00% |
| TK | -0.36% | $728.26M | +11.06% | 0.00% |
| RSG | -0.37% | $66.05B | +31.79% | 1.04% |
| GSM | 0.38% | $843.60M | -8.18% | 0.86% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| UUU | -21.30% | $4.97M | -41.89% | 0.00% |
| ETR | -20.54% | $32.14B | +49.00% | 3.05% |
| MO | -14.57% | $94.67B | +37.05% | 7.07% |
| WM | -11.95% | $87.92B | +27.58% | 1.34% |
| MCK | -11.81% | $78.15B | +35.51% | 0.42% |
| CIG.C | -10.48% | $2.48B | -3.55% | 0.00% |
| ARC | -9.65% | $146.66M | +18.95% | 5.90% |
| HRL | -9.03% | $16.30B | -8.38% | 3.81% |
| COR | -8.95% | $47.48B | +21.20% | 0.86% |
| HUSA | -8.93% | $16.69M | -11.56% | 0.00% |
| IP | -8.76% | $20.09B | +78.02% | 3.20% |
| RBRK | -8.45% | $8.03B | +38.16% | 0.00% |
| TCTM | -7.98% | $8.10M | -42.99% | 0.00% |
| GAN | -7.98% | $83.39M | +21.19% | 0.00% |
| VERX | -7.73% | $7.99B | +89.70% | 0.00% |
| SCWX | -7.44% | $743.12M | +40.27% | 0.00% |
| OCX | -7.19% | $42.93M | -36.09% | 0.00% |
| LMT | -7.07% | $126.40B | +18.99% | 2.36% |
| NOC | -6.69% | $71.54B | +4.23% | 1.60% |
| IDCC | -6.52% | $4.64B | +83.82% | 0.90% |
ETF's related to CMPS
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 41.67% | $6.58B | 0.35% |
| RSPA | 40.64% | $273.87M | 0% |
| PTH | 40.24% | $143.31M | 0.6% |
| XRT | 40.13% | $451.85M | 0.35% |
| FBT | 39.90% | $1.11B | 0.56% |
| IWO | 39.80% | $12.56B | 0.24% |
| RWJ | 39.53% | $1.75B | 0.39% |
| XSVM | 39.08% | $853.92M | 0.37% |
| EZM | 39.05% | $823.84M | 0.38% |
| IWC | 38.67% | $933.99M | 0.6% |
| PSC | 38.64% | $702.17M | 0.38% |
| GNOM | 38.50% | $70.59M | 0.5% |
| ARKG | 38.44% | $1.13B | 0.75% |
| QQA | 38.40% | $135.01M | 0% |
| VTWO | 38.22% | $12.38B | 0.1% |
| IWM | 38.11% | $75.73B | 0.19% |
| ARKK | 37.92% | $6.28B | 0.75% |
| PRNT | 37.49% | $95.35M | 0.66% |
| SMMD | 37.03% | $1.24B | 0.15% |
| IBB | 36.98% | $6.66B | 0.45% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ULST | 0.02% | $535.47M | 0.2% |
| XONE | -0.26% | $548.88M | 0.03% |
| VTIP | -0.37% | $11.71B | 0.04% |
| FTSM | -0.50% | $6.08B | 0.45% |
| XBIL | -0.52% | $637.70M | 0.15% |
| SCHO | 0.62% | $11.10B | 0.03% |
| UTWO | -0.63% | $447.63M | 0.15% |
| FLRN | 1.07% | $2.33B | 0.15% |
| SGOV | 1.12% | $27.53B | 0.09% |
| IBTE | 1.15% | $1.70B | 0.07% |
| MINT | -1.15% | $11.62B | 0.35% |
| VNLA | 1.21% | $2.27B | 0.23% |
| AGZ | -1.23% | $708.37M | 0.2% |
| GSY | 1.34% | $2.29B | 0.23% |
| CLOI | 1.42% | $715.40M | 0.4% |
| IBDQ | 1.46% | $2.89B | 0.1% |
| BOXX | 1.47% | $4.43B | 0.1949% |
| HDRO | -1.51% | $164.26M | 0.3% |
| FLDR | -1.57% | $595.01M | 0.15% |
| TOTL | 1.63% | $3.31B | 0.55% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -28.57% | $388.04M | 1.43% |
| GBIL | -27.66% | $5.60B | 0.12% |
| VIXY | -19.90% | $195.31M | 0.85% |
| UUP | -17.43% | $309.25M | 0.77% |
| USDU | -16.68% | $201.97M | 0.5% |
| TAIL | -14.81% | $67.98M | 0.59% |
| WEAT | -7.74% | $120.27M | 0.28% |
| BSCO | -7.64% | $2.35B | 0.1% |
| DBE | -7.03% | $50.13M | 0.77% |
| AGZD | -6.50% | $142.76M | 0.23% |
| CORN | -6.19% | $61.12M | 0.2% |
| DBO | -5.32% | $217.57M | 0.77% |
| BILZ | -5.01% | $563.02M | 0.14% |
| SMB | -4.99% | $266.77M | 0.07% |
| IBTG | -4.75% | $1.48B | 0.07% |
| EQLS | -4.73% | $76.08M | 1% |
| XHLF | -4.71% | $874.27M | 0.03% |
| ICLO | -4.44% | $209.30M | 0.2% |
| TBIL | -4.37% | $4.38B | 0.15% |
| KCCA | -4.07% | $220.51M | 0.87% |
News
Yahoo
LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Stifel 2024 Healthcare Conference at 10:55 am ET on November 19, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days
SeekingAlpha
Mind Medicineâs share price has responded very strongly to Q3 update that contained very little new information. Read why I remain bearish on MNMD stock.
SeekingAlpha
Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about FDA approval risks. Click to read.
SeekingAlpha
Compass Pathways is advancing pivotal trials to test psilocybin's impact on treatment-resistant depression. See why I rate CMPS stock as a hold.
Yahoo
Compass Pathways (CMPS) announced yesterday morning with earnings that as a result of changing timelines for its Phase 3 trials, it will be reducing its workforce by approximately 30%, including eliminating some senior management positions, “to further focus the organization and its capital resources on successfully delivering the COMP360 program.” The company’s non-COMP360 preclinical efforts will be stopped and it is “exploring a potential externalization” for its digital health tools. Publish
SeekingAlpha
Compass Pathways plc has exciting developments in treating treatment-resistant depression with the innovative COMP360. Click for more on CMPS stock prospects.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.